| Literature DB >> 31867388 |
Tanya Khaitan1, Anjani Kumar Shukla1, Prashant Gupta1, Shantala R Naik1, Pratik Verma2, Surender Kumar3.
Abstract
BACKGROUND: Smokeless tobacco (SLT) usage contributes about 40% of the total tobacco used in India. Among the 28 known carcinogens in SLT, tobacco-specific nitrosamines are considered to be the most potent. This has challenged the metabolic condition leading to a rise in the inflammatory status, hepatic injury, and apoptosis of the liver and thyroid tissues. Therefore, the present study was undertaken to evaluate the adverse effects of SLT on the liver and thyroid and establish a correlation between them in Jharkhand population.Entities:
Keywords: Liver function test; oral mucosa; smokeless tobacco; thyroid profile
Year: 2019 PMID: 31867388 PMCID: PMC6904959 DOI: 10.4103/jehp.jehp_6_19
Source DB: PubMed Journal: J Educ Health Promot ISSN: 2277-9531
Figure 1Oral mucosal changes showing white lesion (left) and proliferative/ulcerative growth (right)
Graph 1Comparison of serum glutamate-pyruvate transaminase levels in cases and controls
Graph 2Comparison of serum glutamic -oxaloacetic transaminase levels in cases and controls
Graph 3Comparison of serum alkaline phosphatase levels in cases and controls
Graph 4Comparison of serum direct bilirubin levels in cases and controls
Graph 5Comparison of serum indirect bilirubin levels in cases and controls
Graph 6Comparison of serum T3 levels in cases and controls
Graph 7Comparison of serum T4 levels in cases and controls
Correlation of form of smokeless tobacco with liver function test and thyroid profile
| Parameters | Spearman correlation (rho) | |
|---|---|---|
| SGOT | 0.14 | 0.35 |
| SGPT | 0.21 | 0.15 |
| ALP | 0.05 | 0.74 |
| Direct bilirubin | 0.23 | 0.11 |
| Indirect bilirubin | 0.01 | 0.94 |
| T3 | −0.46 | 0.75 |
| T4 | −0.10 | 0.47 |
| TSH | −0.65 | 0.66 |
SGOT=Serum glutamic-oxaloacetic transaminase, SGPT=Serum glutamate-pyruvate transaminase, ALP=Alkaline phosphatase, TSH=Thyroid-stimulating hormone